Statins may lower blood clot risk following joint replacement surgery

Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients. New, first-of-its-kind research presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), found that statins, when used in conjunction with conventional blood clot prevention therapies, significantly reduced the risk for venous thromboembolic (VTE) events following total joint replacement (TJR) surgery.

The number of total hip and surgeries continues to rise each year (more than one million were performed in 2011). And while these procedures are safe and effective, and diminish pain and restore mobility in the vast majority of patients, there is a risk for side effects, including the rare formation of a VTE ─ a blood clot located within a deep vein in the thigh or calf following surgery.

Current, standard VTE prevention techniques include the use of an elastic stocking and/or other external compression device upon admittance to the hospital, patient movement and rehabilitation beginning the first day after surgery and continuing for several months, and anticoagulant therapy (blood thinning medications) starting the night before surgery and continuing after the patient is discharged.

In this new study, researchers reviewed the outcomes of 546 total hip and patients with a minimum of 11 months post-operative follow up. All patients received the standard VTE post-operative therapy, based on AAOS guidelines. Patients who received a revision , a TJR following a fracture, patients with a history of , or patients taking were excluded from the study.

The average patient age was 65.5 years old, and 61 percent of patients were obese with a Body Mass Index (BMI) of 33 kg/m². Patients were divided into two groups: 196 patients who took statins before, during and after surgery (perioperatively); and 221 patients who did not take statins.

The statin group had a significantly lower amount of VTE events (15 patients or 7.7 percent) compared to the non-statin group (32 patients or 14.5 percent).

"Our study found that statins, in addition to conventional venous thromboembolic pharmacologic therapy, significantly reduced the event of VTE in the post-operative period for patients undergoing elective total hip and knee replacements," said Philadelphia-based orthopaedic surgeon and lead study author Katharine T. Criner, MD. "The relative risk of VTE with use of was reduced by 48 percent. Statins not only have lipid-lowering effects, but anti-inflammatory effects that may account for their ability to decrease the development of VTE."

add to favorites email to friend print save as pdf

Related Stories

Aspirin may prevent DVT and PE in joint replacement patients

Feb 07, 2012

Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood ...

Total hip replacement surgery safe for nonagenarian patients

Mar 11, 2014

As more Americans are living well into their 90s, the number of nonagenarian total hip replacement (THR) candidates continues to increase. In the study, "Total Hip Arthroplasty Proves Safe for Nonagenarian Patients," presented ...

Recommended for you

Many older trauma patients would benefit from palliative care

Oct 28, 2014

Half of older adults who sustain injuries severe enough that they could die in the hospital or become unable to function independently are not asked in the intensive care unit (ICU) if they wish to speak with palliative care ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.